Topic · 1 report

Merger Conditions

RegulationWatch reporting on merger conditions matters involving US pharmaceutical manufacturers, PBMs and healthcare companies, newest first.

  1. Merger Conditions

    Amgen remains bound by FTC bundling ban from Horizon Therapeutics acquisition

    The FTC finalised a consent order resolving its challenge, joined by six states, to Amgen's $27.8 billion acquisition of Horizon Therapeutics. The order bars Amgen from bundling its products with Horizon's Tepezza and Krystexxa, requires prior approval for related acquisitions and imposes 15-year compliance obligations under a monitor.